Skip to main content
Immunotherapy
CAR T-Cell Therapy Yields Impressive Responses in Aggressive Blood Cancer
Chase Doyle
Read More
Breast Cancer
Less Is More: Six Months of Traxtuzumab Equivalent to 12 Months in HER2-Positive Breast Cancer
Phoebe Starr
Read More
Immunotherapy
Immunotherapy Combinations “Raising the Bar”
Phoebe Starr
Read More
Screening
High Tumor Microsatellite Instability a Marker for Lynch Syndrome, More Common Condition Than Generally Expected
Wayne Kuznar
Read More
Breast Cancer
First-in-Class Antibody-Drug Conjugate Effective in HER2-Negative Metastatic Breast Cancer
Chase Doyle
Read More
Immunotherapy, Multiple Myeloma
Investigational CAR T-Cell Therapy, bb2121, Shows Durable Responses in Relapsed or Refractory Multiple Myeloma
Read More
Original Research
Retrospective Review of the Use of Oral Chemotherapy Drugs for Patients with Metastatic Renal-Cell Carcinoma
Nathan M. Kawamura, PharmD, BCOP, Sara Griesbach , PharmD, BCPS, BCACP, Sue Wilhelm, RPh, BCPS, Richard Mercier, MD
Read More
Original Research
Comparing Grade 4 Neutropenia Associated with Pegfilgrastim Administered via the Onpro Device versus Manual Injection with a Prefilled Syringe
Caroline Townley, PharmD, Courtney Porter, PharmD, BCOP, Nicole McMullen, PharmD, BCOP
Read More
Case Reports
Undetectable Everolimus Level from Probable Drug–Drug Interaction with Phenobarbital
Jaclynne Metayer, PharmD, Marina Rozov, PharmD, BCPS
Read More
Symptom Management Overview
Management of Rasburicase-Induced Hemolytic Anemia
David A. Kaland, PharmD, BCOP, Michelle A. Borg, PharmD
Read More
Page 157 of 198
Results 1561 - 1570 of 1974